Unihealth Hospitals
- Market cap
- ₹ 785 Cr.
- P/E
- 35x
- P/B
- 5.42x
- 52-week range
- 153.55 – 820
- ROE
- 21%
- ROCE
- 24%
- Dividend yield
- 0%
- Debt / equity
- 0.24
- Sector
- Healthcare Services
- Industry
- Hospital
- Listed on
- NSE SME
About
Unihealth Hospitals Limited is an India-based company, which provides complete health solutions across India and multiple geographies in Africa. Under its flagship UMC Hospitals brand, the Company operates a cumulative bed-strength of approximately 200 tertiary care beds across its facilities in Uganda, Nigeria, and Tanzania. The Company is also providing consultancy services for projects, under varying operational stages, with a bed-strength approximately 1,000 beds in India and multiple African countries. Its businesses include Hospitals & Medical Centers, Healthcare Consultancy, Distribution & Trade, and Medical Value Travel. It is a distributor for medical consumables, pharmaceuticals, nutraceuticals, and medical equipment manufactured by Indian manufacturers. It has specialized medical centers in Tanzania. It also exports wide range of general medical consumables and medical equipment from India to various countries in Africa.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Hospital: 41 companies →Unihealth Hospitals against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)35 against a typical 48.9: cheaper than most peers (1st = cheapest).13th of 40
- Sales growth+140.7% against a typical +21.1% from a year earlier.2nd of 34
- Profit growth+183.3% against a typical +13% from a year earlier.1st of 31
- Share price, 3 months−23.1% against a typical −10.9%.31st of 34
- Size₹ 785 Cr. market value against a typical ₹ 1,306.7 Cr. (1st = largest).20th of 36
Latest announcements
Exchange filings and their impact on the company.
- Allotted 2 lakh preferential shares, adding ~Rs 11 cr equity and ~11% dilution.
Unihealth Hospitals allotted 200,000 equity shares on October 14, 2026 under a preferential issue. The issue price and allottees were not disclosed in the extract, but at the current price of about Rs 554 this implies proceeds of about Rs 11 crore. The new shares expand equity by about 11-12% and modestly strengthen net worth to fund growth and working capital needs.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CRISIL | Withdrawn | — | 18 Aug 2025 |
Every agency has withdrawn its rating.
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 18 Aug 2025 | Withdrawn | — | — | CRISIL | ₹ 2 Cr. |
Fund raises
QIPs, preferential issues, warrants and rights issues, one row per filing, newest first. Open a row for details. All fund raise updates
| Stage | Details | |||||
|---|---|---|---|---|---|---|
| 14 Oct 2026 | Preferential issue | Allotted | — | — | — |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 3 Jul 2026 | Fund Raising | To consider Fund Raising |
| 29 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 14 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 23 May 2025 | Financial Results | To consider and approve the financial results for the period ended March 31, 2025 |
| 10 Mar 2025 | Fund Raising | To consider Fund Raising |
| 11 Nov 2024 | Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 22 | 27 | 43 | 56 | 67 | 65 |
| Expenses | 15 | 16 | 28 | 34 | 35 | 43 |
| Operating Profit | 7 | 10 | 15 | 21 | 32 | 22 |
| OPM % | 32% | 39% | 35% | 38% | 48% | 34% |
| Other Income | 1 | 1 | 2 | 1 | 3 | 2 |
| Interest | 2 | 2 | 2 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 2 | 4 | 4 | 6 |
| Profit before tax | 5 | 8 | 13 | 18 | 30 | 17 |
| Tax % | 17% | 28% | 29% | −2% | 4% | −2% |
| Net Profit | 4 | 6 | 9 | 18 | 29 | 17 |
| EPS in Rs | — | — | — | — | 9.75 | 6.83 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 38%
- 3 Years
- 44%
- TTM
- 33%
- 10 Years
- —
- 5 Years
- 39%
- 3 Years
- 49%
- TTM
- 81%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 70%
- TTM
- —
- 10 Years
- —
- 5 Years
- 20%
- 3 Years
- 19%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Unihealth Hospitals | ₹ 564.95 | ₹ 785 Cr. | 35x | 5.4x | 21% | — |
| Apollo Hospitals Enterprise | ₹ 7,731.95 | ₹ 1,11,174 Cr. | 64.9x | 13.4x | 22% | 7.8% |
| Max Healthcare Institute | ₹ 817.00 | ₹ 79,519 Cr. | 71.5x | 9.9x | 14.3% | 17.2% |
| Fortis Healthcare | ₹ 720.00 | ₹ 54,357 Cr. | 67.9x | 7.3x | 11.1% | 11.7% |
| Aster DM Healthcare | ₹ 651.00 | ₹ 56,817 Cr. | 102.6x | 9.3x | 9.7% | 9.2% |
| Narayana Hrudayalaya | ₹ 1,667.25 | ₹ 33,862 Cr. | 48.1x | 9.1x | 19.9% | 10.3% |
Management
- Akshay Mahendra Parmar
- Chairman of the Board, Managing Director
- Parag Rajnikant Shah
- Chief Financial Officer, Whole-Time Director
- Binita Mayur Patel
- Chief Compliance Officer, Company Secretary
Prices are delayed and for information only. Nothing on this page is investment advice.